SCHEMBL21268106

SCHEMBL21268106

CC(C(=O)N1CCN2c3ccccc3C[C@H]2C1)N1CCN(C)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ SIGMAR1 Q99720 11/20 1.00
▸ GAA P10253 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ HTR2B P41595 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ ADAM10 O14672 1/20 0.43
▸ ERBB2 P04626 1/20 0.43
▸ MMP2 P08253 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ TDP1 Q9NUW8 1/20 0.42
▸ ATM Q13315 1/20 0.41
▸ DRD2 P14416 1/20 0.40
▸ HRH3 Q9Y5N1 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16197791 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL16197621 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL21268109 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL16197282 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL16197372 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL16197676 1.00 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL16197550 0.92 SIGMAR1 (0.85) SIGMAR1GAASMN1; SMN2ADAM10ERBB2
SCHEMBL16197396 0.89 SIGMAR1 (0.80) SIGMAR1GAASMN1; SMN2HTR2AHTR2C
SCHEMBL21268107 0.87 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2KDM4EALDH1A1
SCHEMBL21278134 0.87 SIGMAR1 (1.00) SIGMAR1GAASMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2989104-B1 PYRAZINO[1,2-A]INDOLE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE PHARMACEUTICALS SA (ES) 2019-08-21 — — EP claimed
Send feedback